https://ipharmag.com/article/teva-tev408-il15-celiac-disease-phase-2a iPharmag en 2026-09-02T15:31:17+00:00 Teva’s Antibody Protected the Gut From Gluten in a Celiac Disease Trial https://ipharmag.com/article/roche-simcere-sim0660-tri-specific-b-cell-deal iPharmag en 2026-09-02T15:31:17+00:00 Roche Pays Up to $1.53B for Simcere’s Three-Armed Antibody Targeting Autoimmune Disease https://ipharmag.com/article/obesity-immune-cell-memory-epigenetic iPharmag en 2026-09-02T15:31:17+00:00 Obesity Leaves a Lasting ‘Memory’ in Immune Cells — Even After Weight Loss https://ipharmag.com/article/fall-vaccination-guidelines-flu-covid-rsv-2026 iPharmag en 2026-09-02T15:31:17+00:00 Major Medical Societies Issue Fall Vaccination Guidance for Flu, COVID and RSV https://ipharmag.com/article/biotak-score-takotsubo-broken-heart-syndrome-test iPharmag en 2026-09-02T15:31:17+00:00 A Blood Test Can Tell ‘Broken Heart Syndrome’ From a Real Heart Attack https://ipharmag.com/article/pharmaessentia-besremi-essential-thrombocythemia-fda-approval iPharmag en 2026-09-02T04:04:01+00:00 FDA Approves Besremi for Essential Thrombocythemia — the First New Treatment in Nearly 30 Years https://ipharmag.com/article/mit-single-cell-striatum-atlas-neurological-disorders iPharmag en 2026-09-02T04:04:01+00:00 A Cell-by-Cell Map of a Key Brain Region Reveals Which Neurons Disease Hits Hardest https://ipharmag.com/article/gsk-mrna-flu-vaccine-two-antigen-ha-na iPharmag en 2026-09-02T04:04:01+00:00 GSK Bets Two Targets Beat One in the Race for a Better mRNA Flu Vaccine https://ipharmag.com/article/florida-sues-pbms-express-scripts-prime-price-fixing iPharmag en 2026-09-02T04:04:01+00:00 Florida Sues Two Big Drug Middlemen, Alleging They Fixed Prices to Squeeze Pharmacies https://ipharmag.com/article/arrowhead-plozasiran-severe-hypertriglyceridemia-phase-3 iPharmag en 2026-09-02T04:04:01+00:00 Arrowhead’s RNA Drug Cut Triglycerides ~80% and Slashed Pancreatitis in Phase 3 https://ipharmag.com/article/stryker-sportsuite-vision-apple-vision-pro-fda iPharmag en 2026-09-01T16:30:13+00:00 FDA Clears the First Surgical App for Apple’s Vision Pro Headset https://ipharmag.com/article/paxlovid-long-covid-no-benefit-trial iPharmag en 2026-09-01T16:30:13+00:00 Extended Paxlovid Didn’t Help Long Covid, Rigorous Trial Finds https://ipharmag.com/article/novartis-remibrutinib-ms-pill-phase-3 iPharmag en 2026-09-01T16:30:13+00:00 Novartis’s Oral MS Pill Beats a Standard Drug in Two Big Trials https://ipharmag.com/article/alumis-tyk2-envudeucitinib-lupus-failure iPharmag en 2026-09-01T16:30:13+00:00 Alumis Shares Crater 55% After Its Lupus Drug Misses in a Mid-Stage Trial https://ipharmag.com/article/ad109-sleep-apnea-pill-synairgy-cpap-alternative iPharmag en 2026-09-01T16:30:13+00:00 A Pill for Sleep Apnea Cut Breathing Interruptions by 44% in a Phase 3 Trial https://ipharmag.com/article/tnbc-lox-dhodh-one-two-punch-ferroptosis iPharmag en 2026-09-01T05:19:52+00:00 A ‘One-Two Punch’ Forces Aggressive Breast Cancer Cells to Self-Destruct https://ipharmag.com/article/novartis-bristol-myers-pause-autoimmune-car-t-safety iPharmag en 2026-09-01T05:19:52+00:00 Novartis and Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Signals https://ipharmag.com/article/migraine-prevention-guidelines-2026-cgrp iPharmag en 2026-09-01T05:19:52+00:00 First Major Migraine-Prevention Guidelines Since 2012 Elevate Newer Drugs https://ipharmag.com/article/lilly-merida-2-9-billion-autoimmune-buyout iPharmag en 2026-09-01T05:19:52+00:00 Lilly Buys Merida Biosciences for Up to $2.9B to Target Autoimmune Disease at Its Source https://ipharmag.com/article/flu-vaccine-galectin-1-immune-cells iPharmag en 2026-09-01T05:19:52+00:00 A Surprising Lung Immune Cell Could Help Build Better Flu Vaccines